Tevogen (TVGN) Ending Cash Balance (2021 - 2026)
Tevogen's Ending Cash Balance was $1.08 million in Q2 2026, up 57.9% from $685,229 a year earlier and up 56.3% from the prior quarter.
Powered by 
Analysis
Tevogen (TVGN) Ending Cash Balance (2021 - 2026) Analysis & Trends
For FY2025, Ending Cash Balance at Tevogen came in at $552,372, down 56.9% from FY2024.
- Ending Cash Balance shows a four-year compound annual growth rate of 12.5% (FY2021 to FY2025).
- In earlier years, Ending Cash Balance was $1.28 million in FY2024 (+21.9%), $1.05 million in FY2023 (-80.8%), $5.48 million in FY2022 and $344,581 in FY2021.
- The Q2 2026 figure marks the highest quarterly Ending Cash Balance since Q1 2025.
- Compared with a year earlier, Ending Cash Balance was higher in three of the last eight quarters, with an average decline of 12.2%.
- The best year-over-year quarter for Ending Cash Balance over five years was Q2 2026 (growth of 57.9%); the worst was Q4 2023 (a decline of 80.8%).
- Per Business Quant data, TVGN's Ending Cash Balance in the three quarters before Q2 2026 was $692,305 (Q1 2026), $552,372 (Q4 2025) and $1.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.89 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.88 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 1.03 Bn |
| 10 | Tevogen | 27.79 Mn | 27.79 Mn | - | 1.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.08 Mn |
| Mar 31, 2026 | 692,305.00 |
| Dec 31, 2025 | 552,372.00 |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 685,229.00 |
| Mar 31, 2025 | 1.97 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 3.46 Mn |
| Mar 31, 2023 | 5.67 Mn |
| Dec 31, 2022 | 5.48 Mn |
| Sep 30, 2022 | 143,047.00 |
| Jun 30, 2022 | 185,645.00 |
| Mar 31, 2022 | 231,546.00 |
| Dec 31, 2021 | 344,581.00 |
API Access
Tevogen Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=TVGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "TVGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=TVGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();